Position in FATE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$117,954
+$103,363 QoQ
Shares Held
98,295
+560.2% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mariner, LLC holds $324,140,503 across 135 Biotechnology names. FATE ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
123,954 | $95,771,817 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,600 | $58,764,661 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
557,361 | $29,384,071 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
268,901 | $15,190,217 | |
| 5 | EXEL |
Exelixis, Inc.
|
307,928 | $13,207,031 | |
| 6 | INCY |
Incyte Corp
|
121,091 | $11,397,084 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,948 | $9,908,894 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
40,016 | $7,565,024 |
All Filings in FATE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,954 | 98,295 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,591 | 14,889 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,891 | 22,930 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,921 | 11,537 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||